U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    ACTA2-AS1 ACTA2 antisense RNA 1 [ Homo sapiens (human) ]

    Gene ID: 100132116, updated on 17-Sep-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis.

    Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis.
    Wu S, Zhu J, Jiang T, Cui T, Zuo Q, Zheng G, Li G, Zhou J, Chen X., Free PMC Article

    01/16/2024
    Long Noncoding RNA ACTA2-AS1 Inhibits Cell Growth and Facilitates Apoptosis in Gastric Cancer by Binding with miR-6720-5p to Regulate ESRRB.

    Long Noncoding RNA ACTA2-AS1 Inhibits Cell Growth and Facilitates Apoptosis in Gastric Cancer by Binding with miR-6720-5p to Regulate ESRRB.
    Hu Z, Chen Z, Jiang W, Fang D, Peng P, Yao S, Luo M, Wang L, Sun Z, Wang W, Wang X, Mao H, Ai F, Zhou P.

    11/28/2023
    lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.

    lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.
    Peng Y, Huang X, Wang H., Free PMC Article

    08/6/2022
    Overexpression of long non-coding RNA ACTA2-AS1 inhibits the viability, proliferation, migration and invasion of colorectal cancer cells.

    Overexpression of long non-coding RNA ACTA2-AS1 inhibits the viability, proliferation, migration and invasion of colorectal cancer cells.
    Wu X, Pang Q, Zhi F, Mao X, Hu Y.

    06/11/2022
    Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a.

    Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a.
    Lin C, Zheng M, Yang Y, Chen Y, Zhang X, Zhu L, Zhang H., Free PMC Article

    04/30/2022
    Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2.

    Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2.
    Liu X, Zhang X, Du S., Free PMC Article

    04/23/2022
    ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.

    ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.
    Ying K, Wang L, Long G, Lian C, Chen Z, Lin W.

    07/10/2021
    Enhanced expression of lncRNA ZXF1 promotes cisplatin resistance in lung cancer cell via MAPK axis.

    Enhanced expression of lncRNA ZXF1 promotes cisplatin resistance in lung cancer cell via MAPK axis.
    Yu T, Bai W, Su Y, Wang Y, Wang M, Ling C.

    12/19/2020
    Downregulation of long non-coding RNA ZXF1 restricts cell survival by targeting miR-634-GRB2 in lung adenocarcinoma.

    Downregulation of long non-coding RNA ZXF1 restricts cell survival by targeting miR-634-GRB2 in lung adenocarcinoma.
    Ren X, Xu N, Zhang Y, Wang T.

    11/21/2020
    Downregulation of ACTA2AS1:4 affects a number of key mechanisms involved in liver cancer progression. These data may be important for the future of liver cancer diagnosis and subsequent treatments.

    Knockdown of ACTA2‑AS1 promotes liver cancer cell proliferation, migration and invasion.
    Zhou RJ, Lv HZ.

    05/25/2019
    mRNAs were differentially expressed in the HepG2 cell line after the down-regulation of long noncoding rna-UC001kfo.

    Differential expression of genes in HepG2 cells caused by UC001kfo RNAi as shown by RNA-seq.
    Pan YF, Su T, Chen LD, Qin T.

    05/5/2018
    firstprevious page of 1 nextlast